Synthesis, Characterization and Docking Study of Novel Pyrimidine Derivatives as Anticancer Agents

New compounds 5 and 9 using DNA bases e.g. Adenine 1 and Guanine 6 derivatives have been synthesized. The use of simple methods to synthesize compounds 5 and 9 were done using pyrimidine as an alternative DNA base ring. Another design to synthesize new simple pyrimidine rings utilizing thiourea and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Manal Mohamed Talaat El-Saidi, Ahmed Ali El-Sayed, Erik Bjerregaard Pedersen, Mohamed Abdelhamid Tantawy, Nadia Ragab Mohamed, Wafaa Ahmed Gad
Formato: article
Lenguaje:EN
Publicado: Department of Chemistry, Universitas Gadjah Mada 2020
Materias:
dna
Acceso en línea:https://doaj.org/article/1c908f0187b34998b8860e0523c3b79b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1c908f0187b34998b8860e0523c3b79b
record_format dspace
spelling oai:doaj.org-article:1c908f0187b34998b8860e0523c3b79b2021-12-02T11:27:25ZSynthesis, Characterization and Docking Study of Novel Pyrimidine Derivatives as Anticancer Agents1411-94202460-157810.22146/ijc.50582https://doaj.org/article/1c908f0187b34998b8860e0523c3b79b2020-07-01T00:00:00Zhttps://jurnal.ugm.ac.id/ijc/article/view/50582https://doaj.org/toc/1411-9420https://doaj.org/toc/2460-1578New compounds 5 and 9 using DNA bases e.g. Adenine 1 and Guanine 6 derivatives have been synthesized. The use of simple methods to synthesize compounds 5 and 9 were done using pyrimidine as an alternative DNA base ring. Another design to synthesize new simple pyrimidine rings utilizing thiourea and ethylcyano acetate to afford 6-amino-2-thiouracil was adopted. The reaction of thiouracil 10 with chloro cyano or chloro ester and ketone, resulted in the formation of adduct compounds 18-21, rather than the formation of compound 17. All the synthesized compounds were subjected to docking study, in order to gain insights into their binding modes against cyclin-dependent protein kinase 2 (CDK-2) that is involved heavily in cell cycle regulation and receptor protein B-cell lymphoma 2 (BCL-2) which is involved in cell apoptosis. These targets were selected based on their key roles in cancer progression via the regulation of the cell cycle and DNA replication. Molecular-docking analyses showed that compound 14e was the best docked ligand against both targets, as it displayed the lowest binding energy, critical hydrogen bonds and hydrophobic interactions with the targets.Manal Mohamed Talaat El-SaidiAhmed Ali El-SayedErik Bjerregaard PedersenMohamed Abdelhamid TantawyNadia Ragab MohamedWafaa Ahmed GadDepartment of Chemistry, Universitas Gadjah Madaarticlednaguanidineadenine6-aminothiouracilhydrazonoyl halidesthiadiazolephenylisocyanatemolecular dockingChemistryQD1-999ENIndonesian Journal of Chemistry, Vol 20, Iss 5, Pp 1163-1177 (2020)
institution DOAJ
collection DOAJ
language EN
topic dna
guanidine
adenine
6-aminothiouracil
hydrazonoyl halides
thiadiazole
phenylisocyanate
molecular docking
Chemistry
QD1-999
spellingShingle dna
guanidine
adenine
6-aminothiouracil
hydrazonoyl halides
thiadiazole
phenylisocyanate
molecular docking
Chemistry
QD1-999
Manal Mohamed Talaat El-Saidi
Ahmed Ali El-Sayed
Erik Bjerregaard Pedersen
Mohamed Abdelhamid Tantawy
Nadia Ragab Mohamed
Wafaa Ahmed Gad
Synthesis, Characterization and Docking Study of Novel Pyrimidine Derivatives as Anticancer Agents
description New compounds 5 and 9 using DNA bases e.g. Adenine 1 and Guanine 6 derivatives have been synthesized. The use of simple methods to synthesize compounds 5 and 9 were done using pyrimidine as an alternative DNA base ring. Another design to synthesize new simple pyrimidine rings utilizing thiourea and ethylcyano acetate to afford 6-amino-2-thiouracil was adopted. The reaction of thiouracil 10 with chloro cyano or chloro ester and ketone, resulted in the formation of adduct compounds 18-21, rather than the formation of compound 17. All the synthesized compounds were subjected to docking study, in order to gain insights into their binding modes against cyclin-dependent protein kinase 2 (CDK-2) that is involved heavily in cell cycle regulation and receptor protein B-cell lymphoma 2 (BCL-2) which is involved in cell apoptosis. These targets were selected based on their key roles in cancer progression via the regulation of the cell cycle and DNA replication. Molecular-docking analyses showed that compound 14e was the best docked ligand against both targets, as it displayed the lowest binding energy, critical hydrogen bonds and hydrophobic interactions with the targets.
format article
author Manal Mohamed Talaat El-Saidi
Ahmed Ali El-Sayed
Erik Bjerregaard Pedersen
Mohamed Abdelhamid Tantawy
Nadia Ragab Mohamed
Wafaa Ahmed Gad
author_facet Manal Mohamed Talaat El-Saidi
Ahmed Ali El-Sayed
Erik Bjerregaard Pedersen
Mohamed Abdelhamid Tantawy
Nadia Ragab Mohamed
Wafaa Ahmed Gad
author_sort Manal Mohamed Talaat El-Saidi
title Synthesis, Characterization and Docking Study of Novel Pyrimidine Derivatives as Anticancer Agents
title_short Synthesis, Characterization and Docking Study of Novel Pyrimidine Derivatives as Anticancer Agents
title_full Synthesis, Characterization and Docking Study of Novel Pyrimidine Derivatives as Anticancer Agents
title_fullStr Synthesis, Characterization and Docking Study of Novel Pyrimidine Derivatives as Anticancer Agents
title_full_unstemmed Synthesis, Characterization and Docking Study of Novel Pyrimidine Derivatives as Anticancer Agents
title_sort synthesis, characterization and docking study of novel pyrimidine derivatives as anticancer agents
publisher Department of Chemistry, Universitas Gadjah Mada
publishDate 2020
url https://doaj.org/article/1c908f0187b34998b8860e0523c3b79b
work_keys_str_mv AT manalmohamedtalaatelsaidi synthesischaracterizationanddockingstudyofnovelpyrimidinederivativesasanticanceragents
AT ahmedalielsayed synthesischaracterizationanddockingstudyofnovelpyrimidinederivativesasanticanceragents
AT erikbjerregaardpedersen synthesischaracterizationanddockingstudyofnovelpyrimidinederivativesasanticanceragents
AT mohamedabdelhamidtantawy synthesischaracterizationanddockingstudyofnovelpyrimidinederivativesasanticanceragents
AT nadiaragabmohamed synthesischaracterizationanddockingstudyofnovelpyrimidinederivativesasanticanceragents
AT wafaaahmedgad synthesischaracterizationanddockingstudyofnovelpyrimidinederivativesasanticanceragents
_version_ 1718395926302687232